<SEC-DOCUMENT>0001213900-25-085030.txt : 20250905
<SEC-HEADER>0001213900-25-085030.hdr.sgml : 20250905
<ACCEPTANCE-DATETIME>20250905161502
ACCESSION NUMBER:		0001213900-25-085030
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250905
DATE AS OF CHANGE:		20250905

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollomics Inc.
		CENTRAL INDEX KEY:			0001944885
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94041
		FILM NUMBER:		251296922

	BUSINESS ADDRESS:	
		STREET 1:		989 EAST HILLSDALE BLVD.
		STREET 2:		STE 220
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		1-650-209-4055

	MAIL ADDRESS:	
		STREET 1:		989 EAST HILLSDALE BLVD.
		STREET 2:		STE 220
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Maxpro Investment Co., Ltd
		CENTRAL INDEX KEY:			0002023743
		ORGANIZATION NAME:           	
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		NO.89, SONGREN RD., XINYI DIST.
		CITY:			TAIPEI CITY 11073
		STATE:			F5
		ZIP:			5F-4
		BUSINESS PHONE:		886277137952

	MAIL ADDRESS:	
		STREET 1:		NO.89, SONGREN RD., XINYI DIST.
		CITY:			TAIPEI CITY 11073
		STATE:			F5
		ZIP:			5F-4
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Maxpro Investment Co., Ltd -->
          <cik>0002023743</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Class A ordinary shares, Par Value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/03/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001944885</issuerCik>
        <issuerName>Apollomics Inc.</issuerName>
        <issuerCusip>G0411D123</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>989 E. Hillsdale Blvd.,</com:street1>
          <com:street2>Suite 220</com:street2>
          <com:city>Foster City</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94404</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Maxpro Investment Co., Ltd</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>105071.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>105071.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>105071.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.90</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Apollomics Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>989 E. Hillsdale Blvd., Suite 220, Foster City, CA, 94404, United States of America</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Maxpro Investment Co. Ltd (the "Reporting Person")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>5F-4, No.89, Songren Rd., Xinyi District., Taipei City, Taiwan 11073</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Cayman Islands</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>FI</typeOfPersonFiling>
        <otherTypeOfPersonFiling>Investment company</otherTypeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Explanatory Note:

The Statement on Schedule 13G originally filed with the Securities and Exchange Commission on May 20, 2024, as amended by Amendment No. 1 filed on May 30, 2024, is hereby amended and supplemented by this Amendment No. 2 (this "Amendment").

As of the date of this filing, the Reporting Person may be deemed to beneficially own 105,071 Class A Ordinary Shares, consisting of (i) 101,248 Class A Ordinary Shares and (ii) 3,823 Class A Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of the date of this filing.

As reported on Form 6-K filed by the Issuer, on September 3, 2025, the Issuer issued 1,042,803 Class A Ordinary Shares in a private placement with certain qualified institutional buyers and accredited investors.

As a result of such private placement, the Reporting Person ceased to be the beneficial owner of more than 5 percent of the Issuer's Class A Ordinary Shares. Accordingly, this Amendment constitutes an exit filing for the Reporting Person.

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.</amountBeneficiallyOwned>
        <classPercent>The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

The percentages used herein are calculated based upon 2,146,151 Class A Ordinary Shares issued and outstanding as of the date of this filing.  On April 3, 2025, the Issuer had 1,103,348 Class A Ordinary Shares issued and outstanding, as reported in the Issuer's Form 20-F, filed with the Securities and Exchange Commission on April 3, 2025. As reported on Form 6-K filed by the Issuer on September 3, 2025, the Issuer issued 1,042,803 Class A Ordinary Shares in a private placement with certain qualified institutional buyers and accredited investors.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to an investment company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Maxpro Investment Co., Ltd</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Yi Kuei Chen</signature>
        <title>Yi Kuei Chen / Director</title>
        <date>09/05/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
